University at Buffalo Helps to Launch Two Zimbabwe National Programs in Nanotechnology and HIV/AIDS Eradication
April 15, 2013
A University at Buffalo (UB) research team led by Gene Morse, Pharm.D., associate director of the Translational Pharmacology Core and professor of the New York State Center of Excellence in Bioinformatics and Life Sciences, traveled to Zimbabwe for a week-long series of workshops that marked the launch of two national programs, the Zimbabwe International Nanotechnology Center (ZINC) and Zimbabwe Evidence-to-Action (ETA), a project to end HIV/AIDS in Zimbabwe. The workshops trained students and scientists in Zimbabwe and served as an opportunity to identify shared areas for research and prioritize research in Zimbabwe. Fourteen percent of the Zimbabwe population has both HIV and TB, and there is a pressing need for new drugs and novel formulations of existing drugs.
University at Buffalo
04.05.2013; Sara Saldi
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)